Hence, considering the public health burden of both obesity and elevated hs-CRP levels, obesity-targeted prevention and management strategies are warranted to prevent and ameliorate future inflammation and risk of CVD. Here, MAP3K14 is linked to obesity due to melanocortin 4 receptor deficiency.